ClinicalTrials.Veeva

Menu

Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD (PANDA-H)

N

Nantes University Hospital (NUH)

Status

Active, not recruiting

Conditions

ADHD

Treatments

Other: Pandah Application smartphone only

Study type

Interventional

Funder types

Other

Identifiers

NCT04857788
RC20_0070

Details and patient eligibility

About

Attention Deficit Disorder with or without Hyperactivity (ADHD) is a frequent pathology in children that has important consequences on schooling both in terms of academic level (due to the attentional disorder) and behavior (disruption of the class). ADHD also has an impact on family functioning, which can generate stress and family altercations. The homework period can be a particularly tense time and a source of conflict with the child, which has negative consequences on the family atmosphere, learning efficiency and of course academic success.

The investigators wish to evaluate an innovative digital device (a smartphone application) to accompany the child during homework periods.

Enrollment

264 estimated patients

Sex

All

Ages

9 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 9-16 years old with ADHD assessed by Conners 3 scales
  • Parents and children giving informed consent
  • Patients in follow-up list of participant centers
  • Patients with unchanging care for the last 3 months (medication and therapy)

Exclusion criteria

  • Patients with severe psychiatric disease such as schizophrenia, bipolar disorder, or autism spectrum disorders and suicidal behavior (all assessed by Child Behavior Checklist Scale)
  • Patients with no smartphone or not easy access to smartphone (ie patients of social facilities, internship...)
  • Patients with mild to severe mental retardation or that may obviously not be able to use the app
  • Patients included in special program other the Care as Usual (defined in the ADHD French network) in follow-up list.
  • Patients with Methylphenidate treatment or change of titration for less than 3 months.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

264 participants in 2 patient groups

Pandah Application only
Experimental group
Description:
Design is a controlled randomized Study with two parallel arms after randomization with a three months follow-up of the two arms that are (Group 1) Care as usual for patients in follow-up list; (Group 2) PANDAH App proposed alone with only 15-20 minutes setup with investigator at start-up (digital accompaniment only); Patients of the 2 groups will have a three months follow-up period before secondary evaluation and entering into the so-called extension period.
Treatment:
Other: Pandah Application smartphone only
Care as usual
No Intervention group
Description:
Design is one period of 3 months with 2 parallel groups (with or without application) following by extension period of 3 months with all subject accessing to the application.

Trial contacts and locations

9

Loading...

Central trial contact

Olivier Bonnot, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems